Showing 1231-1240 of 1635 results for "".
- Nicox and Fera Pharmaceuticals to Focus on a Rare Disease Indication for Naproxcinodhttps://modernod.com/news/nicox-and-fera-pharmaceuticals-to-focus-on-a-rare-disease-indication-for-naproxcinod/2479837/Nicox SA and Fera Pharmaceuticals announced that they have amended their 2015 license agreement, which grante
- BlephEx Names Fred Ellis CEOhttps://modernod.com/news/blephex-names-fred-ellis-ceo/2480014/BlephEx has announced that Fred Ellis is the company’s new CEO. Mr. Ellis comes to BlephEx with 29+ years of experience with Alcon-Novartis. While there, he held numerous positions of increased responsibility overseeing a wide range of commercial assignments. He is recognized for having exception
- Zeiss Names New Chief Financial Officerhttps://modernod.com/news/zeiss-names-news-chief-financial-officer/2480025/Christian Müller, PhD, will become Chief Financial Officer of Carl Zeiss AG, succeeding Thomas Spitzenpfeil who, as previously announced, will leave the company. Dr. Müller has been CFO of the Zeiss subsidiary Carl Zeiss Meditec AG since 2009. He joined the Zeiss Group in 2002 as head of Corporat
- Nation’s Ophthalmologists Remind Congress of the Importance of Medical and Surgical Eye Carehttps://modernod.com/news/nations-ophthalmologists-remind-congress-of-the-importance-of-medical-and-surgical-eye-care/2480227/More than 400 eye physicians and surgeons from across the United States are in Washington DC to urge Congress to preserve every patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the
- Thomas W. Samuelson, MD, Named 2018 ASCRS Presidenthttps://modernod.com/news/thomas-w-samuelson-md-named-2018-ascrs-president/2480251/Thomas W. Samuelson, MD, a world-renowned ophthalmologist who specializes in the medical and surgical treatment of glaucoma and disorders of the anterior segment, will assume his role as president of the American Society of Cataract and Refractive Surgery (ASCRS) in April 2018. He currently serve
- Tilak Receives Positive Opinion in Europe for Early Reimbursement of Odysight Telemonitoring Devicehttps://modernod.com/news/tilak-receives-positive-opinion-for-early-reimbursement-of-odysight-telemonitoring-device/2484169/Paris-based Tilak Healthcare has received a positive opinion from the French National Health Authority (Haute Autorité de Santé, HAS) for the reimbursement of Odysight under the PECAN (Prise En Charge Anticipée des dispositifs m&
- NICE Approves First NHS Treatment for Leber Hereditary Optic Neuropathy (LHON)https://modernod.com/news/nice-approves-first-nhs-treatment-for-leber-hereditary-optic-neuropathy-lhon/2484140/The UK-based National Institute for Health and Care Excellence (NICE) has approved idebenone (Raxone; Chiesi Pharmaceuticals) for the treatment of Leber Hereditary Optic Neuropathy (LHON) in patients aged 12 years and older. This marks the first time NICE has
- Neurolens, Maker of Contoured Prism Technology, Rebrands as Newtonhttps://modernod.com/news/neurolens-maker-of-contoured-prism-technology-rebrands-as-newton/2484138/Neurolens announced its official rebrand to Newton. Named in honor of Sir Isaac Newton, the company said the rebrand reflects Newton’s broader vision to build on its foundation of innovative lens technology and continue driving outcomes that help pa
- Prevent Blindness Forms New Diabetes + the Eyes Advisory Committeehttps://modernod.com/news/prevent-blindness-forms-new-diabetes-the-eyes-advisory-committee/2482934/Prevent Blindness has created a new Diabetes + the Eyes Advisory Committee. The volunteer panel will guide national initiatives to raise awareness, expand access to care, and improve early detection of diabetes-related eye diseases.
- Heidelberg Publishes Eye2Gene Study Evaluating Potential of AI-Powered Analysishttps://modernod.com/news/heidelberg-publishes-eye2gene-study-evaluating-potential-of-ai-powered-analysis/2482900/Heidelberg Engineering has publised the Eye2Gene study in Nature Machine Intelligence. Titled “Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene,” the study highlights the pot